肝癌根治性切除术后高血糖与肝癌复发的相关因素分析

Related factors of liver cancer recurrence associated with hyperglycemia after radical resection of liver cancer

  • 摘要: 目的:探讨肝癌根治性切除术后空腹血糖升高与肝癌早期复发的关系。
    方法:采用回顾性队列研究方法。收集2009年10月至2013年6月南方医科大学南方医院145例肝癌患者的临床资料。 患者行肝癌根治性切除术,将术后空腹血糖<6.1mmol/L设为血糖正常组(111例),将术后空腹血糖≥ 6.1 mmol/L设为血糖升高组(34例)。观察患者术后住院以及随访期间的血糖水平,分析两组患者肝癌早期复发情况及影响复发的危险因素。采用门诊随访,术后6个月内每个月复查1次,半年后每3个月复查1次,以术后首次复发为终点,随访时间截至2015年7月1日。收集患者以下资料:(1)性别、年龄、空腹血糖、基础肝病、术前AFP、ALT、AST、ChildPugh分级、巴塞罗那(BCLC)分期、饮酒史;(2)手术资料:手术方式、手术时间、术中输血例数、术中输血量;(3)病理学资料:肿瘤组织学分化程度、肿瘤结节数目、肿瘤最大直径、肝硬化;(4)随访资料:术后AFP、影像学检查情况、复发时间、进行预防性化疗。正态分布的计量资料以±s表示,采用t检验,偏态分布的计量资料以M(范围)表示,采用非参数检验。计数资料采用χ2检验。以术后首次复发为终点事件,采用KaplanMeier法绘制无瘤生存曲线,无瘤生存率的比较采用Logrank检验。影响复发的因素先采用KaplanMeier进行比例风险假定的检验,符合要求者采用Logrank检验进行单因素分析。多因素分析采用COX多因素回归模型。
    结果:患者术后1、2年总体肝癌复发率分别为28.3%(41/145)和45.5%(66/145),其中血糖正常组分别为21.6%(24/111)和36.9%(41/111),血糖升高组分别为50.0%(17/34)和73.5%(25/34),两组比较,差异有统计学意义(χ2=10.335,14.053,P< 0.05)。单因素分析结果显示:空腹血糖、ChildPugh分级、术中输血量、术后AFP是影响肝癌患者肝癌根治性切除术后无瘤生存率的危险因素(χ2=17.591,6.492,10.690,12.820,P<0.05)。血糖正常组及血糖升高组患者术后24个月无瘤生存率分别为63.1%和26.5%,两组比较,差异有统计学意义(χ2=17.591, P<0.05)。多因素分析结果显示:空腹血糖≥6.1 mmol/L、术中输血量>200 mL、术后AFP>8.1 μg/L是影响肝癌患者肝癌根治性切除术后无瘤生存率的独立危险因素(RR=2.542,2.028,2.724,95%可信区间:1.529~4.225,1.183~3.479,1.635~4.538,P<0.05)。
    结论:肝癌患者肝癌根治性切除术后空腹血糖水平升高促进肝癌早期复发,术后进行血糖监控对预防肝癌早期复发有重要意义。

     

    Abstract: Objective:To investigate the related factors of early liver cancer recurrence associated with elevated fasting glucose levels after radical resection of liver cancer.
    Methods:The retrospective cohort study was adopted. The clinical data of 145 patients with liver cancer who were admitted to the Nanfang Hospital of Southern Medical University from October 2009 to June 2013 were collected. After radical resection of liver cancer, 111 patients with average level of fasting blood glucose (FBG)<6.1 mmol/L and 34 patients with level of FBG≥ 6.1 mmol/L were divided into the normal group and the hyperglycemic group, respectively. The blood glucose levels of patients during the period of hospital stay and followup were observed. The status of early recurrence and risk factors affecting recurrence in the 2 groups were analyzed. Followup of outpatient examination was applied to patients up to July 1, 2015 with the first recurrence as the end point. Patients had reexaminations once every month within postoperative month 6 and once every 3 months after 6 months. The general information [gender, age, FBG,underlying hepatopathy, preoperative AFP, alanine transaminase (ALT), aspartate aminotransferase (AST), ChildPugh stage, Barcelona Clinic Liver Cancer (BCLC) stage, history of alcohol drinking], surgical data (surgical method, operation time, number of blood transfusion, volume of intraoperative blood loss), pathological data (histopathological differentiation, number of tumor nodules, diameter of maximal tumor, liver cirrhosis) and followup data(postoperative AFP, imaging findings, recurrence time, preventive chemotherapy) were collected. Measurement data with normal distribution were presented as ±s and analyzed by the t test. Measurement data with skewed distribution were presented as M (range) and analyzed by the nonparametric test. Count data were analyzed using the chisquare test. With the first recurrence as the end point, the tumorfree survival rate was drawn using the KaplanMeier method, and the comparison was analyzed by the logrank test. The risk factors affecting recurrence were analyzed using the KaplanMeier method for proportional hazards assumption test firstly, and then eligible factors were done using Logrank test in the univariate analysis. The multivariate analysis was done using the COX model.
    Results:The postoperative  1, 2year overall recurrence rates of liver cancer were 28.3%(41/145) and 45.5%(66/145). And 1, 2year  recurrence rates of liver cancer were 21.6%(24/111) and 36.9%(41/111) in the normal group and 50.0% (17/34) and 73.5% (25/34) in the hyperglycemic group, respectively, showing significant differences between the 2 groups (χ2= 10.335, 14.053, P<0.05). The univariate analysis showed that FBG, ChildPugh stage, volume of intraoperative blood transfusion and postoperative AFP were risk factors affecting tumorfree survival rate after radical resection of liver cancer (χ2=17.591, 6.492, 10.690,12.820, P<0.05). The tumorfree survival rates at postoperative month 24 in the normal group and hyperglycemic group were 63.1% and 26.5% respectively, showing significant difference between the 2 groups (χ2=17.591, P<0.05). The results of multivariate analysis showed that level of FBG≥6.1 mmol/L, volume of intraoperative blood transfusion>200 mL and postoperative level of AFP>8.1 μg/L were independent risk factors affecting tumorfree survival rate after radical resection of liver cancer (RR=2.542, 2.028, 2.724, 95% condifence interval: 1.529-4.225,1.183-3.479,1.635-4.538, P<0.05).
    Conclusions:Elevated FBG level has a stimulative effect on early recurrence of tumor after radical resection of liver cancer. As a result, monitoring and controlling of blood glucose after operation is helpful in decreasing the early recurrence rate of patients with liver cancer.

     

/

返回文章
返回